Immunity conferred by Aro- Salmonella live vaccines. 1991

C E Hormaeche, and H S Joysey, and L Desilva, and M Izhar, and B A Stocker
Department of Pathology, University of Cambridge, U.K.

The specificity of protection conferred by Aro- salmonellae was studied in BALB/c mice challenged 3 months after intravenous (i.v.) vaccination, more than 1 month after the vaccine had been cleared. Oral challenge showed better protection than i.v. challenge. Salmonella typhimurium aroA SL3261 conferred very good protection against wild-type S. typhimurium C5 (over 10,000 x LD50). Cross protection experiments were performed using S. typhimurium, S. enteritidis and S. dublin for vaccination and challenge, including variants of S. typhimurium and S. enteritidis of similar virulence differing in the main LPS antigen (O-4 or O-9). Salmonella typhimurium aroA conferred solid protection against S. typhimurium (O-4), but no protection against wild-type S. enteritidis (O-9). However challenge with LPS variant strains showed that although protection was generally better to strains of the homologous LPS type, specificity of protection was determined more by the parent strain background (S. typhimurium or S. enteritidis) of the challenge than by O-factors 4 or 9, suggesting that other antigens are involved. The nature of the protective antigen(s) in this model is unclear, but it does not appear to be the main O-specific antigen. A S. enteritidis Se795 aroA vaccine gave good protection against wild-type S. enteritidis Se795 2 weeks after vaccination, but much less at 3 months (approximately 10-200 x LD50), although the persistence of the S. enteritidis aroA vaccine in the liver and spleen was similar to that of the S. typhimurium vaccine, and the wild-type Se795 challenge strain was of similar virulence to S. typhimurium C5. A S. dublin aroA vaccine conferred similar protection against wild-type S. dublin (approximately 300 x LD50).

UI MeSH Term Description Entries
D007110 Immunity, Active Resistance to a disease agent resulting from the production of specific antibodies by the host, either after exposure to the disease or after vaccination. Active Immune Response,Active Immune Responses,Active Immunities,Active Immunity,Immune Response, Active,Immune Responses, Active,Immunities, Active,Response, Active Immune,Responses, Active Immune
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008297 Male Males
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D005260 Female Females
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001428 Bacterial Vaccines Suspensions of attenuated or killed bacteria administered for the prevention or treatment of infectious bacterial disease. Bacterial Vaccine,Bacterin,Vaccine, Bacterial,Vaccines, Bacterial
D012477 Salmonella enteritidis A serotype of Salmonella enterica which is an etiologic agent of gastroenteritis in man and other animals. Salmonella enterica serovar enteritidis
D012481 Salmonella Infections, Animal Infections in animals with bacteria of the genus SALMONELLA. Animal Salmonella Infection,Animal Salmonella Infections,Infection, Animal Salmonella,Infections, Animal Salmonella,Salmonella Infection, Animal

Related Publications

C E Hormaeche, and H S Joysey, and L Desilva, and M Izhar, and B A Stocker
December 1976, Lancet (London, England),
C E Hormaeche, and H S Joysey, and L Desilva, and M Izhar, and B A Stocker
April 1997, Immunology,
C E Hormaeche, and H S Joysey, and L Desilva, and M Izhar, and B A Stocker
July 1988, The Veterinary record,
C E Hormaeche, and H S Joysey, and L Desilva, and M Izhar, and B A Stocker
February 1978, British medical journal,
C E Hormaeche, and H S Joysey, and L Desilva, and M Izhar, and B A Stocker
January 2015, Canadian journal of veterinary research = Revue canadienne de recherche veterinaire,
C E Hormaeche, and H S Joysey, and L Desilva, and M Izhar, and B A Stocker
May 2008, Cancer letters,
C E Hormaeche, and H S Joysey, and L Desilva, and M Izhar, and B A Stocker
July 1992, Nihon saikingaku zasshi. Japanese journal of bacteriology,
C E Hormaeche, and H S Joysey, and L Desilva, and M Izhar, and B A Stocker
November 1993, Veterinary microbiology,
C E Hormaeche, and H S Joysey, and L Desilva, and M Izhar, and B A Stocker
March 2001, Science (New York, N.Y.),
C E Hormaeche, and H S Joysey, and L Desilva, and M Izhar, and B A Stocker
June 2021, Avian diseases,
Copied contents to your clipboard!